PlainRecalls
FDA Devices Moderate Class II Ongoing

ARIES SARS-CoV-2 Assay

Reported: August 24, 2022 Initiated: July 14, 2022 #Z-1524-2022

Product Description

ARIES SARS-CoV-2 Assay

Reason for Recall

SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.

Details

Recalling Firm
Luminex Corporation
Units Affected
257
Distribution
U.S. Nationwide distribution in the states of NE, TX, MS, TN, KY, ME, CA.
Location
Austin, TX

Frequently Asked Questions

What product was recalled?
ARIES SARS-CoV-2 Assay. Recalled by Luminex Corporation. Units affected: 257.
Why was this product recalled?
SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 24, 2022. Severity: Moderate. Recall number: Z-1524-2022.